328 related articles for article (PubMed ID: 9312232)
21. Worldwide distribution of HTLV.
Tajima K
Jpn J Cancer Res; 1998 Jan; 89(1):inside front cover. PubMed ID: 9510466
[No Abstract] [Full Text] [Related]
22. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
Guerena-Burgueno F; Benenson AS; Sepulveda-Amor J; Ascher MS; Vugia DJ; Gallo D
Am J Trop Med Hyg; 1992 Aug; 47(2):127-32. PubMed ID: 1503181
[TBL] [Abstract][Full Text] [Related]
23. Low human T cell leukemia virus type II seroprevalence in Africa.
Bonis J; Verdier M; Dumas M; Denis F
J Infect Dis; 1994 Jan; 169(1):225-7. PubMed ID: 8277189
[No Abstract] [Full Text] [Related]
24. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
25. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
[TBL] [Abstract][Full Text] [Related]
26. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
[TBL] [Abstract][Full Text] [Related]
27. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors.
Bellei NC; Granato CF; Tomyiama H; Castelo A; Ferreira O
Trans R Soc Trop Med Hyg; 1996; 90(2):122-5. PubMed ID: 8761567
[TBL] [Abstract][Full Text] [Related]
28. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
Barcellos NT; Fuchs SC; Mondini LG; Murphy EL
Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the South Bronx, New York.
Factor SH; Irwin KL; Lal RB; Rudolph D; Weber TJ; Olivo N; Ernst J
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):97-7. PubMed ID: 8624769
[No Abstract] [Full Text] [Related]
30. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group.
Soriano V; Calderón E; Esparza B; Cilla G; Aguilera A; Gutiérrez M; Tor J; Pujol E; Merino F; Pérez-Trallero E
Int J Epidemiol; 1993 Aug; 22(4):716-9. PubMed ID: 8225748
[TBL] [Abstract][Full Text] [Related]
31. Unusual finding of HTLV-I infection among Amazonian Amerindians.
Barros Kanzaki LI; Casseb J
Arch Med Res; 2007 Nov; 38(8):897-900. PubMed ID: 17923274
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
33. Transplant and organ donor-associated transmission of human T-lymphotropic virus types I and II.
Maté G; González C; Bronsoms JM; Vallés M; Torguet P; Mauri JM
Transplant Proc; 1995 Aug; 27(4):2417. PubMed ID: 7652859
[No Abstract] [Full Text] [Related]
34. Human T lymphotropic virus 1-2 positive antibodies in potential organ donors in France.
Claquin J; Romano P; Noury D; Borsarelli J; Jacob F; Feuillerat JP; Colpart JJ
Transplant Proc; 1996 Feb; 28(1):189-90. PubMed ID: 8644172
[No Abstract] [Full Text] [Related]
35. Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.
Olaleye DO; Bernstein L; Sheng Z; Ekweozor CC; Li XY; Sullivan-Halley J; Rasheed S
Am J Trop Med Hyg; 1994 Apr; 50(4):479-86. PubMed ID: 8166356
[TBL] [Abstract][Full Text] [Related]
36. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
de Araujo AC; Casseb JS; Neitzert E; de Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L
Eur J Epidemiol; 1994 Apr; 10(2):165-71. PubMed ID: 7813694
[TBL] [Abstract][Full Text] [Related]
37. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
Dipierri JE; Tajima K; Cartier Robirosa L; Sonoda S
Medicina (B Aires); 1999; 59(6):717-20. PubMed ID: 10752214
[TBL] [Abstract][Full Text] [Related]
38. [HTLV-I AND HTLV-II in Spain].
An Med Interna; 1995 Jun; 12(6):299-306. PubMed ID: 7548650
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
[TBL] [Abstract][Full Text] [Related]
40. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]